PATHEON INC Financial Statements (2025 and earlier)
Company Profile
| Business Address |
C/O PATHEON PHARMACEUTICALS SERVICES INC DURHAM, NC 27703 |
| State of Incorp. | |
| Fiscal Year End | October 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)
| 10/31/2013 | |||
|---|---|---|---|
| ASSETS | |||
| Current Assets | |||
| Cash, cash equivalents, and short-term investments | |||
| Cash and cash equivalents | |||
| Receivables | |||
| Inventory, net of allowances, customer advances and progress billings | |||
| Inventory | |||
| Income taxes receivable | |||
| Other undisclosed current assets | |||
| Total current assets: | |||
| Noncurrent Assets | |||
| Property, plant and equipment | |||
| Intangible assets, net (including goodwill) | |||
| Goodwill | |||
| Intangible assets, net (excluding goodwill) | |||
| Deferred costs | |||
| Other noncurrent assets | |||
| Defined benefit plan, assets for plan benefits | |||
| Investments and other noncurrent assets | |||
| Other undisclosed noncurrent assets | |||
| Total noncurrent assets: | |||
| TOTAL ASSETS: | |||
| LIABILITIES AND EQUITY | |||
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities, including: | |||
| Taxes payable | |||
| Employee-related liabilities | |||
| Other undisclosed accounts payable and accrued liabilities | |||
| Debt | |||
| Deferred revenue and credits | |||
| Deferred tax liabilities | |||
| Other undisclosed current liabilities | |||
| Total current liabilities: | |||
| Noncurrent Liabilities | |||
| Long-term debt and lease obligation | |||
| Long-term debt, excluding current maturities | |||
| Liabilities, other than long-term debt | |||
| Deferred revenue and credits | |||
| Pension and other postretirement defined benefit plans, liabilities | |||
| Deferred compensation liability, classified | |||
| Deferred tax liabilities, net | |||
| Postemployment benefits liability | |||
| Other liabilities | |||
| Other undisclosed noncurrent liabilities | |||
| Total noncurrent liabilities: | |||
| Total liabilities: | |||
| Equity | |||
| Equity, attributable to parent | |||
| Common stock | |||
| Additional paid in capital | |||
| Accumulated other comprehensive income | |||
| Accumulated deficit | |||
| Total equity: | |||
| TOTAL LIABILITIES AND EQUITY: | |||
Income Statement (P&L) ($ in millions)
| 10/31/2013 | ||
|---|---|---|
| Revenues | ||
| Cost of revenue (Cost of Goods and Services Sold) | ||
| Other undisclosed gross profit | ||
| Gross profit: | ||
| Operating expenses | ||
| Other undisclosed operating income | ||
| Operating income: | ||
| Nonoperating income | ||
| Loss, foreign currency transaction, before tax | ||
| Other nonoperating income | ||
| Income from continuing operations before equity method investments, income taxes: | ||
| Other undisclosed loss from continuing operations before income taxes | ||
| Loss from continuing operations before income taxes: | ||
| Income tax benefit | ||
| Loss from continuing operations: | ||
| Loss before gain (loss) on sale of properties: | ||
| Loss from discontinued operations | ||
| Net loss available to common stockholders, diluted: | ||
Comprehensive Income ($ in millions)
| 10/31/2013 | ||
|---|---|---|
| Net loss: | ||
| Comprehensive loss: | ||
| Other undisclosed comprehensive loss, net of tax, attributable to parent | ||
| Comprehensive loss, net of tax, attributable to parent: | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.